Michael Kaseta
CIK 1724346 · CFO and COO · last filed 2026-04-16
Michael Kaseta is a CFO and COO who has filed 49 SEC Form 4 insider transactions across 4 companies since 2017. The most recent filing, for LQDA, was dated Apr 16, 2026. Across all open-market trades the lifetime net is −$16.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $29.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$29.14M
4
49
-$16.74M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LQDA | CFO and COO | 408,775 | $71.23 | $29.12M | -$16.74M | 40 | 2026-04-16 |
| HRTX | Director | 53,960 | $0.40 | $21.6K | $0 | 4 | 2026-02-03 |
| ALIMERA SCIENCES INC (ALIM) Delisted | Director | — | $5.54 | — | $0 | 2 | 2023-10-04 |
| Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Chief Financial Officer | 15,000 | — | — | $0 | 2 | 2018-03-19 |
Recent Filings
49 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-16 | LQDA | Mixed | −52,419 | -$5.46M | EDGAR |
| 2026-04-14 | LQDA | Mixed | −6,080 | -$1.62M | EDGAR |
| 2026-04-13 | LQDA | Mixed | — | -$5.01M | EDGAR |
| 2026-03-03 | LQDA | Mixed | +1,179 | -$35.6K | EDGAR |
| 2026-02-03 | HRTX | Grant (A) | +53,960 | $0 | EDGAR |
| 2026-01-21 | LQDA | Grant (A) | +59,320 | $0 | EDGAR |
| 2026-01-13 | LQDA | Mixed | −2,904 | -$1.38M | EDGAR |
| 2025-12-02 | LQDA | Mixed | +1,177 | -$37.5K | EDGAR |
| 2025-10-15 | LQDA | Mixed | −5,802 | -$272.3K | EDGAR |
| 2025-09-03 | LQDA | Mixed | +1,196 | -$33.3K | EDGAR |